Alexander V. Shpektor

Alexander V. Shpektor

Auto-generated profile, based on publicly available information

Alexander V. Shpektor

Yevdokimov Moscow State University of Medicine and Dentistry

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
IMIgor V. Maev
Igor V. Maev
ASA. V. Shpektor
A. V. Shpektor
EVE. Yu. Vasilyeva
E. Yu. Vasilyeva
VMV. N. Manchurov
V. N. Manchurov
DADmitrii Nikolaevich Andreev
Dmitrii Nikolaevich Andreev
ВЮВасильева Елена Юрьевна
Васильева Елена Юрьевна
The novel coronavirus infection COVID-19 in most cases manifests with respiratory symptoms and fever, however, some patients may have cardiovascular and gastroenterological manifestations. A feature of the clinical syndrome of COVID-19 is the development of pronounced immunopathological reactions and disorders of hemostasis, leading to the development of a wide range of cardiovascular complications. The course of COVID-19 may be complicated by the development of acute myocardial infarction, venous and arterial thrombosis and thromboembolism in various vascular pools, the development of acute myocardial damage and myocarditis. Among the gastroenterological manifestations, diarrhea, nausea or vomiting, as well as abdominal pain, are most often detected. These symptoms may precede the appearance of respiratory signs of the disease, and in some cases come to the fore in the clinical picture of the disease. In addition, in some patients there are laboratory signs of liver injury (increased serum transaminases). The exact pathogenesis of the above disorders continues to be studied.

8 July 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
OAO. V. Averkov
O. V. Averkov
OBOlga Barbarash
Olga Barbarash
SBSergey Boytsov
Sergey Boytsov
EVElena Vasilieva
Elena Vasilieva
ODOxana M. Drapkina
Oxana M. Drapkina
МГМ. Ю. Гиляров
М. Ю. Гиляров
Дифференцированный подход в диагностике, формулировке диагноза, ведении больных и статистическом учете инфаркта миокарда 2 типа (согласованная позиция)

5 September 2016 in Platelets
Verified
Journal Article
Open access
Murad VagidaMurad Vagida
Murad Vagida
AAAnush Arakelyan
Anush Arakelyan
ALAnna Lebedeva
Anna Lebedeva
JGJean-Charles Grivel
Jean-Charles Grivel
ASAlexander Shpektor
Alexander Shpektor
LMLeonid Margolis
Leonid Margolis
A diverse population of small extracellular vesicles (EVs) that are released by various cells has been characterized predominantly in bulk, a procedure whereby the individual characteristics of EVs are lost. Here, we used a new nanotechnology-based flow cytometric analysis to characterize the antigenic composition of individual EVs in patients with acute coronary syndrome (ACS). Plasma EVs were captured with 15-nm magnetic nanoparticles coupled to antibodies against CD31 (predominantly an endothelial marker), CD41a (a marker for platelets), and CD63 or MHC class I (common EV markers). The total amounts of EVs were higher in the ACS patients than in the controls, predominantly due to the contribution of patients with acute myocardial infarction. For all captured fractions, the differences in the EV amounts were restricted to CD41a+ EVs. The increase in the numbers of EVs in the ACS patients, predominantly of platelet origin, probably reflects platelet activation and may indicate disease progression.

24 September 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AKAnna Kalinskaya
Anna Kalinskaya
PSP. P. Savvinova
P. P. Savvinova
EVElena Vasilieva
Elena Vasilieva
ASA. V. Shpektor
A. V. Shpektor
Aim. To assess the processes of clot formation in relation to endogenic fibrinolysis in patients with various types of acute coronary syndrome (ACS).Material and methods. To the study, 89 persons (40 males) included: 59 with ACS, 30 — control group. Among the ACS patients, 28 were ST-elevation (STEMI), 31 with non-ST-elevation ACS (NSTEACS). All participants were assessed for clotting formation parameters and thrombus lysis with rotational elastometry on ROTEM equipment (Germany) and “Hemacore” Thrombodynamics (Russia), before coronary arteriography.Results. Clot density and its size in 10 minutes were significantly higher in ACS comparing to control patients (2867 units vs 25084 units, p<0,001; 41,8 mm vs 36,4 mm, p<0,05, respectively). The time from onset of thrombus lysis was lower in ACS (79,4 min vs 69,3 min, p<0,05). The percent of lysis by the end of process registration was lower in ACS (20,1% vs 23,1%, p<0,05). Amplitude of clot formation in 20 minutes from the onset of clotting, as the maximum density of clot were significantly higher in NSTEACS comparing to STEMI (56,2 mm vs 49,7 mm, p=0,018; 59 mm vs 53,2 mm, p=0,011; respectively). Thrombus lysis was slower in NSTEACS patients comparing to STEMI (62,26 min vs 45,5 min, p=0,02).Conclusion. With the measurement in vitro, the process of clotting and thrombus lysis is more active in ACS patients comparing to controls, that point on a baseline activated hemostasis. Within the ACS group, higher the existing clot in vessel lumen, more active the shift of the balance to anticoagulation and fibrinolysis.

4 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AKAnna Kalinskaya
Anna Kalinskaya
ODOleg Dukhin
Oleg Dukhin
IMIvan Molodtsov
Ivan Molodtsov
AMAlexandra Maltseva
Alexandra Maltseva
DSDenis Sokorev
Denis Sokorev
EVElena Vasilieva
Elena Vasilieva
With the progress of COVID-19 studies, it became evident that SARS-CoV-2 infection is often associated with thrombotic complications. The goal of our present study was to evaluate which component of clot formation process including endothelial function, platelets aggregation and plasma coagulation, as well as endogenous fibrinolysis in patients with COVID-19 correlates with the severity of the disease. We prospectively included 58 patients with COVID-19 and 47 healthy volunteers as a control group that we recruited before the pandemic started. It turns out that plasma coagulation with subsequent platelet aggregation, but not endothelial function, correlates with the severity of the COVID-19. IL-6 blockade may play a beneficial role in COVID-19 induced coagulopathy.

23 June 2023 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
IRIu. I. Rachkova
Iu. I. Rachkova
OSO. A. Sergeeva
O. A. Sergeeva
MGM. V. Gorev
M. V. Gorev
SNSh. G. Nardaia
Sh. G. Nardaia
NGN. A. Gaidukova
N. A. Gaidukova
ASA. V. Shpektor
A. V. Shpektor
Aim. Cryoballoon ablation (CBA) is one of the methods for catheter pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (AF). Left atrial additional lesion (LAAL) to PVI were proposed to eliminate extrapulmonary AF triggers. Nonetheless whether the additional lesions improve CBA effectiveness is not clear.Methods. Primary CBA procedures performed for paroxysmal AF during 2017-2021 were analyzed. The study group (Algorithm group, n=82) was recruited prospectively in 2019-2021. As the first step CBA PVI were performed in all pts. In those who were on sinus rhythm (SR) after the PVI, AF induction attempts with burst atrial pacing were performed. Pts with induced AF and those who stayed on AF after PVI underwent LAAL at the left ganglionated plexus area. In case of stable SR (non-inducible AF) the procedure finished. If AF was inducible or did not terminate during CBA, the second LAAL set were performed - LA posterior wall lesions. If AF was still inducible or did not terminate, the SR was restored by electrical cardioversion. The control group (Control group, n=94) was formed retrospectively from patients with routinely performed only CBA PVI with achievement of isolation criteria in 2017-2019. If AF continued, sinus rhythm was restored by cardioversion. There were no attempts of induction AF during the procedure.Results. The Algorithm and Control groups were comparable in terms of clinical, demographic and electrophysiological characteristics. At 12 months postoperatively, the effectiveness was higher in the Algorithm group than in the Control group (78.0% vs. 62.8%, p = 0.044). No adverse effects were found.Conclusion. Thus, the stepwise approach with LAAL increases the effectiveness of CBA in the long-term period and does not affect the risk of complications.